Navigation Links
Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
Date:11/1/2007

orning, November 1, 2007. A conference call and accompanying slides will be webcast live at 8:00 a.m. ET and may be accessed by visiting the Investors section of the Company's website at: http://www.millennium.com.

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (JJPRD). Millennium is responsible for commercialization of VELCADE in the U.S., Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Millennium and Ortho Biotech Inc. are co-promoting VELCADE in the U.S. VELCADE is approved in more than 80 countries worldwide.

In the U.S., VELCADE is indicated for the treatment of patients with multiple myeloma who have received at least one prior therapy. VELCADE is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol. VELCADE should be administered under the supervision of a physician experienced in the use of antineoplastic therapy. In the European Union and many other countries worldwide, VELCADE is approved for patients with multiple myeloma after first relapse.

Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis syndrome. Women of childbearing potential should avoid becoming pregnant while being treated with VELCADE. Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. Acute development or exacerbation of c
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... tension to a chain of carbon atoms can turn ... to Rice University scientists. , Stretching the material known ... atoms -- by just 3 percent can begin to ... useful for mechanically activated nanoscale electronics and optics. , ... his colleagues appears in the American Chemical Society journal ...
(Date:7/21/2014)... Sleep disturbances such as insomnia, hypersomnia, ... depression. According to a study published by the ... of depressed patients have insomnia symptoms, and hypersomnia ... adults and 10% of older patients, with a ... have a major impact on quality of life, ...
(Date:7/18/2014)... Mich. , July 18, 2014  Neogen Corporation ... Stephen Snyder , Neogen,s chief operating officer and president, ... he will work as a consultant going forward on ... Snyder has been in this position since September ... fulfilled by James Herbert , who has been ...
(Date:7/18/2014)... Hungary & Cambridge, MA (PRWEB) July 18, 2014 ... , headquartered in Budapest with US offices in ... HLA™ - a combination Assay and Software product ... (NGS), for use on the Illumina® MiSeq sequencing ... through collaboration with The Children’s Hospital of Philadelphia ...
Breaking Biology Technology:Carbyne morphs when stretched 2Carbyne morphs when stretched 3Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3
... on Growth Opportunities, NEW YORK, May 30 ... and CEO Charles O. Holliday, Jr., said the,company ... macro trends related to food, safety and security, ... company," Holliday said at the,Sanford Bernstein Strategic Decisions ...
... (Nasdaq:,PCOP), an innovator in the discovery and development ... is implementing the next,step in its ongoing effort ... later-stage discovery programs. This effort includes an immediate,workforce ... of positions as well as a decrease in ...
... 2b Clinical Trial Sites in ... ... today announced that PTC124, the company,s orally delivered,investigational new drug for the ... at Myology 2008, the Third,Annual Congress of Myology, on Friday, May 30 ...
Cached Biology Technology:DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy 2DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy 3Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 2Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 3Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs 4PTC124 Featured at Third Annual Congress of Myology 2PTC124 Featured at Third Annual Congress of Myology 3PTC124 Featured at Third Annual Congress of Myology 4
(Date:7/21/2014)... a professor of entomology and cooperating faculty ... the University of California, Riverside, has been awarded the ... of Chemical Ecology ( ISCE ). , Awarded first ... the society,s highest honor. It is awarded annually to ... the study of chemicals that mediate interactions between living ...
(Date:7/21/2014)... BLOOMINGTON, Ind. -- Want to conserve water and save ... Indiana University researcher and published in the current issue ... "The Water Short List: The Most Effective Actions U.S. ... households can reduce water use substantially by simple actions ... habits involving water consumption. While the suggestions may be ...
(Date:7/21/2014)... and cheating in science are among the topics ... mycology experts in Montreal at the three International ... 27 to August 1, 2014. Some 2,000 participants ... the 14th International Congress of Bacteriology and Applied ... Eukaryotic Microbiology, and the 16th International Congress of ...
Breaking Biology News(10 mins):UC Riverside entomologist receives international honor for chemical ecology contributions 2Researchers provide guide to household water conservation 2Researchers provide guide to household water conservation 3Montreal hosts International Union of Microbiology Societies congresses 2
... The mating habits of marine turtle may help to ... new research led by the University of Exeter. Published today ... Royal Society B , the study shows how the mating ... helping them deal with the fact that global warming is ...
... the world,s orchids, not all forests are equal. In a ... Molecular Ecology , Smithsonian ecologists revealed that an orchid,s fate ... Roughly 10 percent of all plant species are orchids, ... loss has rendered many threatened or endangered. This is partly ...
... whale species commands global attention as a result of ... fate of smaller marine mammals is less understood, specifically ... dolphins, porpoises, manatees, and other warm-blooded aquatic species are ... on the issue, researchers from the Wildlife Conservation Society ...
Cached Biology News:Turtles' mating habits protect against effects of climate change 2Fungi-filled forests are critical for endangered orchids 2Marine mammals on the menu in many parts of world 2Marine mammals on the menu in many parts of world 3
Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...
Request Info...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SSA (Sheep serum albumin) lysine through amide bonds. This product is homologous to NP-BSA....
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
Biology Products: